INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Piramal Pharma Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 543635	ISIN Demat INE0DK501011	Book Value 52.95	NSE Symbol PPLPHARMA	Dividend Yield (%) 0.05	Market Cap (₹ Cr.) 29,186.35	P/E 42.5	EPS 5.18	Face Value 10

Particulars (₹ Cr)	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	4,390.11	3,443.22	3,340.42	2,938.81
Sale of Products	3,980.39	2,968.57	2,915.88	2,477.52
Sale of Services	344.92	436.61	302.94	422.23
Income from Investment and Financial Services	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00
Other Operating Revenue	64.80	38.04	121.60	39.06
Less: Excise Duty / GST	0.00	0.00	0.00	0.00
Revenue From Operations - Net	4,390.11	3,443.22	3,340.42	2,938.81
Other Income	202.06	341.07	224.79	197.97
Total Revenue	4,592.17	3,784.29	3,565.21	3,136.78
Changes in Inventories	-61.62	53.31	-32.66	57.86
Cost of Material Consumed	1,545.55	1,166.48	1,083.93	986.70
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	624.91	548.69	510.24	183.21
Employee Benefits	613.93	548.50	448.03	395.15
Total Other Expenses	1,049.42	1,028.71	855.60	696.96
Manufacturing / Operating Expenses	364.46	367.23	383.66	320.82
Administrative and Selling Expenses	504.34	485.63	427.82	258.75
Other Expenses	180.62	175.85	44.12	117.39
Finance Costs	107.10	115.87	57.29	4.71
Depreciation and Amortization	205.26	192.08	165.37	143.64
Total Expenses	4,084.55	3,653.64	3,087.80	2,468.23
Profit Before Exceptional Items and Tax	507.62	130.65	477.41	668.55
Exceptional Items Before Tax	0.00	-6.96	-15.08	18.23
Profit Before Extraordinary Items and Tax	507.62	123.69	462.33	686.78
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00
Profit Before Tax	507.62	123.69	462.33	686.78
Taxation	116.40	54.19	94.79	115.28
Current Tax	112.48	38.77	110.82	104.98
MAT Credit Entitlement	0.00	0.00	0.00	0.00
Deferred Tax	3.92	15.42	-16.03	10.30
Other Tax	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00
Profit After Tax	391.22	69.50	367.54	571.50
Extraordinary Items After Tax	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	391.22	69.50	367.54	571.50
Adjustments to Net Income	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	391.22	69.50	367.54	571.50
Earning Per Share - Basic	3.05	0.57	3.12	9.11
Earning Per Share - Diluted	3.05	0.57	3.12	9.11
Operation Profit before Depreciation	819.98	438.60	700.07	816.90
Operating Profit after Depreciation	614.72	246.52	534.70	673.26
Dividend Per Share	0.11	0.00	0.00	0.00
Dividend Percentage	1.10	0.00	0.00	0.00
Equity Dividend	14.70	0.00	0.00	0.00
Weighted Average Shares - Basic	128.11	121.27	117.89	62.76
Weighted Average Shares - Diluted	128.35	121.27	117.89	62.76